Lymphoma

Top Story

Ibrutinib effective among patients with rare Bing-Neel syndrome

Ibrutinib effective among patients with rare Bing-Neel syndrome
January 18, 2019
Feature

Corticosteroids, IV antibiotics increase risk for chemotherapy-induced febrile neutropenia

January 17, 2019
Use of corticosteroids, certain dermatologic or mucosal conditions, and antibiotics all appeared to increase risk for chemotherapy-induced febrile neutropenia among a…
FDA News

FDA grants breakthrough therapy designation to zanubrutinib for mantle cell lymphoma

January 16, 2019
The FDA granted breakthrough therapy designation to zanubrutinib for the treatment of adults with mantle cell lymphoma who received at least one prior therapy…
In the Journals Plus

Consolidation radiotherapy use decreasing for pediatric Hodgkin lymphoma despite survival benefit

January 9, 2019
Treatment with chemotherapy followed by radiotherapy improved 5-year OS compared with chemotherapy alone among children with early-stage Hodgkin lymphoma, according to a…
More Headlines »
CME

Multimodality Treatment Strategies for NSCLC: A Symposium at the US Oncology Annual Meeting

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. Approximately 85% of diagnosed lung cancers are non-small…
More »
Video
Meeting News

Severe diarrhea an important side effect of checkpoint inhibitor cancer therapy

June 14, 2018
More »
Resource Centers

CME ABIM MOC

Ace the Case: A 52-Year-Old Man with an Asymptomatic Neck Mass

There is no commercial support for this activity.

This educational activity will discuss the approach to diagnosis and management of a 52-year-old man who presents with…
More »